Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 2
1974 5
1975 41
1976 67
1977 57
1978 77
1979 57
1980 59
1981 91
1982 136
1983 133
1984 182
1985 191
1986 261
1987 297
1988 364
1989 486
1990 574
1991 756
1992 989
1993 1228
1994 1435
1995 1753
1996 1696
1997 1827
1998 2105
1999 2378
2000 2738
2001 2984
2002 3218
2003 3443
2004 3691
2005 4214
2006 4973
2007 5245
2008 5441
2009 5853
2010 6687
2011 7567
2012 7869
2013 8085
2014 7653
2015 7691
2016 6817
2017 6791
2018 6612
2019 6708
2020 6347
2021 5201
2022 1092
2023 339
2024 130

Text availability

Article attribute

Article type

Publication date

Search Results

129,804 results

Results by year

Filters applied: . Clear all
Page 1
Targeting CDK4/6 in patients with cancer.
Hamilton E, Infante JR. Hamilton E, et al. Cancer Treat Rev. 2016 Apr;45:129-38. doi: 10.1016/j.ctrv.2016.03.002. Epub 2016 Mar 8. Cancer Treat Rev. 2016. PMID: 27017286 Free article. Review.
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.
Freeman-Cook K, Hoffman RL, Miller N, Almaden J, Chionis J, Zhang Q, Eisele K, Liu C, Zhang C, Huser N, Nguyen L, Costa-Jones C, Niessen S, Carelli J, Lapek J, Weinrich SL, Wei P, McMillan E, Wilson E, Wang TS, McTigue M, Ferre RA, He YA, Ninkovic S, Behenna D, Tran KT, Sutton S, Nagata A, Ornelas MA, Kephart SE, Zehnder LR, Murray B, Xu M, Solowiej JE, Visswanathan R, Boras B, Looper D, Lee N, Bienkowska JR, Zhu Z, Kan Z, Ding Y, Mu XJ, Oderup C, Salek-Ardakani S, White MA, VanArsdale T, Dann SG. Freeman-Cook K, et al. Cancer Cell. 2021 Oct 11;39(10):1404-1421.e11. doi: 10.1016/j.ccell.2021.08.009. Epub 2021 Sep 13. Cancer Cell. 2021. PMID: 34520734 Free article.
Ruxolitinib.
Becker H, Engelhardt M, von Bubnoff N, Wäsch R. Becker H, et al. Recent Results Cancer Res. 2014;201:249-57. doi: 10.1007/978-3-642-54490-3_16. Recent Results Cancer Res. 2014. PMID: 24756798 Review.
Bivalent SIRT1 inhibitors.
Wang J, Zang W, Liu J, Zheng W. Wang J, et al. Bioorg Med Chem Lett. 2017 Jan 15;27(2):180-186. doi: 10.1016/j.bmcl.2016.11.082. Epub 2016 Nov 27. Bioorg Med Chem Lett. 2017. PMID: 27964881
Allosteric small-molecule kinase inhibitors.
Wu P, Clausen MH, Nielsen TE. Wu P, et al. Pharmacol Ther. 2015 Dec;156:59-68. doi: 10.1016/j.pharmthera.2015.10.002. Epub 2015 Oct 24. Pharmacol Ther. 2015. PMID: 26478442 Review.
Cell-Cycle Therapeutics Come of Age.
Ingham M, Schwartz GK. Ingham M, et al. J Clin Oncol. 2017 Sep 1;35(25):2949-2959. doi: 10.1200/JCO.2016.69.0032. Epub 2017 Jun 3. J Clin Oncol. 2017. PMID: 28580868 Free PMC article. Review.
129,804 results
You have reached the last available page of results. Please see the User Guide for more information.